CATX vs CLOV
Perspective Therapeutics Inc. (CATX) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Perspective Therapeutics Inc. (CATX) is a medical devices company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported CATX revenue for 2023-09-30 was $2.2M. Net income was -$10.4M. Revenue was up 4.6% from 2023-06-30 to 2023-09-30. CATX currently screens at market cap $280.6M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
CATX currently screens at market cap $280.6M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the CATX and CLOV stock pages for the full models.
Not investment advice.